title: [Current therapy of idiopathic Parkinson disease. 1: Diagnosis, therapeutic guidelines, standard pharmacotherapy and physical therapy].
abstract: The necessary prerequisite for adequate medical and physical treatment are early diagnosis and differential diagnosis. The gold standard for medical treatment of Parkinsonism continues to be the administration of L-dopa. However, in view of the complications associated with the long-term use of L-dopa, combination treatment with dopamine agonists and substances presumed to have a neuroprotective effect, for example selegiline, administered at the onset of the disease is currently gaining importance and finding increased interest.
authors.affiliation: Neurologische Klinik, Ruhr-Universität im St.-Josef-Hospital, Bochum.
authors.forename: T
authors.initials: T
authors.lastname: Müller
authors.forename: W
authors.initials: W
authors.lastname: Kuhn
authors.forename: H
authors.initials: H
authors.lastname: Przuntek
mesh_terms: D000978:Antiparkinson Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003131:Combined Modality Therapy; D006801:Humans; D010300:Parkinson Disease / Q000175:diagnosis / Q000534:rehabilitation*; D026741:Physical Therapy Modalities; D017410:Practice Guidelines as Topic
chemical_list: D000978:Antiparkinson Agents